Mayer Brown advises CDPQ on $1.3 billion acquisition of Antylia Scientific with Brookfield

Mayer Brown represented global institutional investor, CDPQ, in the $1.34 billion joint acquisition of Antylia Scientific, a diversified life science tools business serving the pharma, biopharma, healthcare and environmental sectors, together with funds affiliated with global asset manager Brookfield Asset Management. CDPQ is a global investment group managing funds for public pension and insurance plans, known for its long-term, partnership-driven approach across a broad range of asset classes.

The Mayer Brown team was led by Corporate & Securities partner Paul de Bernier (Los Angeles), counsel Karen Chong (New York), and associate Amir Rousta (Northern California) and included: Tax partners Michelle Jewett and Karen Kim, and associate Xiao Xiao; Corporate & Securities partners Tim Clark (all New York) and George O'Brien (Washington DC), and associates Yev Yalon (Northern California) and Danni Taylor (Chicago); Banking & Finance counsel Ali Perry (New York); and Litigation & Dispute Resolution partners Tamer Soliman and Sydney Mintzer, and associates Jennifer Parry, Emily King, Shelby Colson, and Nic Jackson (all Washington DC).